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1. Introduction 
The incidence of kidney disease is rapidly increasing worldwide, fueled by the increasing 
incidences of diabetes and obesity (Centers for Disease Control and Prevention, 2010), and 
thus, more patients with hypertension and diabetes develop end-stage renal disease (ESRD). 
Maintenance hemodialysis has become an established protocol for treating ESRD patients. 
This process is facilitated by two physical phenomena that facilitate mass transfer in 
purifying blood during maintenance hemodialysis. Diffusion caused by a concentration 
gradient between blood and dialysate contributes to the removal of uremic solutes, 
particularly small-size molecules. The removal of excess body water and mid-size molecules 
depend primarily on convective mass transfer, which results from hydraulic and osmotic 
pressure gradients (Daugirdas & Van Stone, 2000). 
Remarkable improvements have been made in the technologies used for renal supportive 
dialysis treatment in ESRD patients. Polymeric membranes better prevent the transfer of 
pyrogenic substances into the blood stream and membrane biocompatibilities are much 
improved (Weber et al., 2004). The sharp molecular cut-offs of these membranes also prevent 
further loss of albumin during high-dose convective treatment (Ahrenholz et al., 2004). 
Narrow pore size distributions and improved hydraulic properties in the membranes field are 
matched by the evolution of various modalities for renal supportive treatment. Furthermore, 
better outcomes achieved by convective treatment have encouraged the use of synthetic 
membranes with high water permeability and sieving characteristics in clinical setups (Woods 
& Nandakumar, 2000), to the extent that hemodiafiltration (HDF) and volume-controlled high-
flux hemodialysis (HD) are now regarded as preferred forms of convective therapy, because 
the retention of middle to large-sized molecules by chronic renal failure patients is closely 
related to renal-failure associated mortality (Leypoldt et al., 1999).  
Volume-controlled high-flux HD adequately clears mid-size solutes without sterile fluid 
infusion. Forward filtration exceeding desired volume removal is compensated for by 
backfiltration (Ofsthun & Leypoldt, 1995), and thus, this modality can provide a simpler 
form of dialysis treatment than other treatment methods. The convective dose delivered 
during high-flux HD has been shown to reduce mortality in patients at risk, as defined by a 
serum albumin level of <4 g/dl (Locatelli et al., 2009). However, overall patient survival 
remains comparable to that of low-flux HD (Eknoyan et al., 2002), which presumably is 
caused by the limited amount of internal filtration involved due to limitations imposed by 
fluid dynamics and the geometric nature of the hemodialyzer. 
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Therefore, HDF is considered the gold standard for high-dose convective therapy, and has 
even been reported to reduce mortality risk as compared with high-flux HD (Canaud et al., 
2006). HDF, which describes an intermittent renal supportive therapy of combined 
simultaneous diffusive and convective solute transport, is characterized by a large filtration 
volume that far exceeds the desired volume removal, and hence, external substitution is 
essential. In early HDF trials, a large number of sterile bags were used to supply substitution 
fluid, which was costly and complicated (Ledebo, 2007). However, technical advances made in 
the production of pyrogen-free ultrapure water allow sterile dialysate to be readily produced, 
which enables on-line based HDF to be used on a clinical basis. Several types of on-line HDF 
are clinically available that differ in terms of the ways in which external replacement fluid is 
administered, such as, by pre- or post-dilution. Due to their unique benefits, mixed forms of 
pre- and post-infusion have also been devised, such as, mixed-dilution or mid-dilution HDF 
(Krieter & Canaud, 2008, Pedrini & De Cristofaro, 2003). However, the inevitable complexities 
associated with HDF machines and patient monitoring, and the requirement for the exogenous 
infusion of replacement fluid is still problematic. Therefore, various modifications of HDF 
strategies have been proposed to integrate HDF and HD modes, that is, to increase convective 
dose without the requirement for external infusion. These modifications can be classified into 
three developmental categories; (1) to increase the internal filtration rate by increasing 
pressure gradients along the hemodialyzer, (2) to use independent domains for forward 
filtration and backfiltration, or ultrafiltration and diffusion, and (3) to alternate forward and 
backward filtration procedures. 
In this chapter, the trials on HDF strategies undertaken without exogenous substitution 
infusion will be discussed in terms of their technical aspects, in vivo and in vitro efficacies 
and applicabilities for clinical use. This is followed by an in-depth review on pulse 
push/pull hemodialysis (PPPHD), a recently introduced pulsatile technique that provides 
infusion-free HDF. 
2. HDF strategies that do not require exogenous substitution infusion 
Hemodiafiltration is an intermittent renal supportive therapy that involves the process of 
convection and diffusion. Total filtration volumes invariably exceed desired amounts and 
this dehydration must be corrected in real time. Despite various modifications of the HDF 
techniques based on infusion modes, the need for external replacement fluid infusion has 
not been eliminated. Accordingly, efforts continue to be made to eliminate exogenous sterile 
fluid infusion during HDF sessions. This is achieved by spontaneous fluid reinfusion at a 
rate that matches convection. Backfiltration and regenerated ultrafiltrate can be the methods 
of spontaneous fluid restoration. 
2.1 Internal Filtration Enhanced HDF (iHDF) 
Internal filtration (IF) is defined as the total water flux across membranes within the closed 
blood and dialysate compartments of a dialyzer (Dellanna et al., 1996). Volume controlled 
high-flux HD is a representative modality to use the internal filtration phenomenon, and 
provides a straightforward means of achieving enhanced convection by augmenting internal 
filtration rates, i.e., forward filtration and backward filtration rates. The amount of internal 
filtration is directly regulated by pressure gradients through the hemodialyzer. A pressure 
drop is inevitable, as fluid flows through a cylindrical tube, and it is expressed by 
Poiseuille’s equation: 
www.intechopen.com
 Pulse Push/Pull Hemodialysis: Convective Renal Replacement Therapy 
 
115 
 
Fig. 1. Blood and Dialysate Pressure Gradient along Dialyzer Length. The sum of hydraulic 
and osmotic pressures is termed TMP, as TMP = ∆Pb- ∆Pd-∆π. Here, ΔPb represents the 
average value of arterial and venous blood pressure, ΔPd for average hydraulic dialysate 
pressures, and Δπ is oncotic pressures. 
 
4
L
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d
   (1) 
Where, ΔP is the pressure drop, µ is the fluid viscosity, L and d are the length and diameter 
of the flow path, and Q the flow rates. Thus, blood and dialysate pressures drop along the 
dialyzers. However, because blood and dialysate flow in opposite directions, these pressure 
drops occur with opposing gradients, and in some region, hydraulic blood and dialysate 
pressures overlap (Fig. 1). In a normal countercurrent dialysis setup, the sum of hydraulic 
and osmotic pressures, termed transmembrane pressure (TMP), is positive in the proximal 
region of a hollow fiber dialyzer, and plasma moves to the dialysate compartment across the 
membranes (forward filtration). However, fluid movement occurs in the opposite direction 
in the distal region, because hydraulic blood pressures are below the sum of dialysate 
compartment pressure and osmotic pressure, and thus, backward filtration occurs and 
compensates for fluid loss in the proximal region.  
2.1.1 Factors influencing internal HDF 
Even though forward and backward filtration rates are highly dependent on membrane 
permeabilities and the degree of membrane fouling, they remain directly proportional to the 
positive and negative TMPs, respectively. As shown in Fig. 1, resulting TMP gradients can 
be readily increased by increasing blood and/or dialysate pressure drops (Fiore & Ronco, 
2004, 2007). For blood, the pressure drop is proportional to blood viscosity and tube length 
in accord with Poiseuille’s equation (Eq. 1), which shows that tube length increases pressure 
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differential. Likewise, blood hematocrit and total protein levels also affect the pressure drop 
through viscosity.  
The diameter of the flow path is another important factor. Poiseuille’s equation shows that 
the pressure drop is inversely proportional to the 4th power of tube diameter, which means 
that membrane (a bundle of hollow fibers) lumen diameter is the predominant factor for 
governing blood pressure drops, and therefore, many investigations of internal HDF have 
focused on dialytic efficiencies using hemodialyzers with smaller membrane diameters. In 
early clinical studies, beta-2 microglobulin (ǃ2M) removal was found to be significantly 
increased when membrane diameter was reduced. A 175 µm diameter dialyzer was found to 
enhance ǃ2M clearances by factors of two and four, respectively, over 200 and 250 µm 
diameter hemodialyzers (Dellanna et al., 1996). Clearances of inulin and vitamin b12 were 
also significantly greater with 175 µm dialyzer than a 200 µm dialyzer, without changing the 
clearances of low molecular weight solutes (Ronco et al., 2000). In addition, a mathematical 
model showed that internal filtration rates increase rapidly with membrane diameter, and 
this theoretical result was also confirmed experimentally (Mineshima, 2004, Mineshima et 
al., 2000). Myoglobin clearance was increased by 34% when a membrane of diameter 150 
µm, rather than 200 µm, with the same surface area was used at the same blood flow rates. 
These benefits in dialytic efficiency afforded by reducing membrane lumen diameter allow 
internal filtration enhanced hemodialyzers to be used clinically (Lucchi et al., 2004, Righetti 
et al., 2010).  
However, the underlying risk of hemoconcentration due to high levels of forward filtration 
may not be negligible. Pressure-driven filtration causes large volume losses from blood and 
promptly increases blood viscosity, which deteriorates membrane sieving and hydraulic 
capabilities. Membrane-binding by blood components like plasma proteins and clots is a 
major cause of permeability reductions, and inevitably diminish membranes efficiencies, 
particularly in the forward filtration region. Nevertheless, membrane fouling, which tends 
to be more of an issue during the early stage of iHDF treatment, tends to have little effect on 
overall membrane transfer capacity during iHDF (Yamamoto et al., 2005). 
Dialysate pressure is also regulated by increasing the flow resistance on the dialysate 
stream. Several techniques can be used to increase dialysate flow resistances, such as 
increasing membrane packing density, lengthening the hemodialyzer, or placing obstacles 
in the dialysate flow path. Obviously, dialyzer length effectively regulates dialysate 
pressure drops. In one study conducted to clarify the effect of dialyzer length on solute 
clearance, middle-to-large uremic molecules, such as ǃ2M and alpha-1 microglobulin (ǂ1M), 
were shown to be better cleared by a 250 mm dialyzer than a 195 mm dialyzer (Sato et al., 
2003). Dialysate pressure drop can also be manipulated by modulating membrane packing 
density. The higher the packing density of membrane fibers, the greater the resistance to 
dialysate flow, because the effective cross-sectional area available for dialysate flow 
decreases. Analytical and experimental studies revealed myoglobin clearances using a 
hemodialyzer with 71.3% packing density were slightly higher than hemodialyzers with 
packing densities of 52% or 60.1% (Mineshima, 2004). However, high hemodialyzer packing 
densities cause substantial degrees of dialysate channeling, and flow mismatch between 
blood and dialysate. This unmatched flow distribution leads to a loss of effective surface 
area and impairs the diffusion process (Gastaldon et al., 2003). Flow visualization studies in 
a dialyzer with a high packing density (75%) reconfirmed this disproportionate flow pattern 
of dialysate, as compared with standard packing density dialyzers (68%), and consequent 
reductions in urea clearance (Fujimura et al., 2004, Yamamoto et al., 2005). Nevertheless, a 
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unique design of housing wall, involving addition of a short taper to the inner housing 
surface effectively prevented the dialysate from being channeled (Fujimura et al., 2004). 
2.1.2 Internal filtration quantification 
The beneficial effects of internal HDF, such as increased middle-size solute clearances, may 
be quantified by evaluating internal filtration rates, because the internal filtration level is 
directly related to delivered convective dose. The flux across a membrane (Q) at a local 
region of the hemodialyzer (x) can be expressed by membrane hydraulic permeability (Kuf 
measured in ml/h/mmHg) and TMP (mmHg), as follows: 
       * ) * (  Q x Kuf x TMP x Kuf x Pb Pd        (2) 
Where, Pb, Pd and π represent the blood, dialysate and osmotic pressures. However, the 
flow dynamics inside the hemodialyzer are so complex that precise determinations of 
internal filtration rates are not available clinically. This is principally because Kuf across 
membranes is neither linearly related to the pressure gradient, nor constant at any position 
in the hemodialyzer (Ficheux et al., 2010). Kuf values are also substantially lowered by 
membrane fouling, which is remarkably affected by blood viscosity, coagulation, the 
abilities of membrane materials to bind plasma proteins, and treatment modalities. Hence, 
fluxes and permeabilities across membranes become parameters beyond the operator’s 
control. Alternatively, a semi-empirical model based on clinical data has been developed to 
determine internal filtration rates. Using this model, internal filtration volumes and 
reinfusion rates were determined during internal HDF and post-dilution HDF modes, and 
revealed that differences between total convections (4.1 and 5.4 L/h for iHDF and HDF) 
well reflected differences between ǃ2M clearance rates (123±11 and 149±26 ml/min for 
iHDF and HDF, respectively) (Lucchi et al., 2004). In a study conducted using in vitro 
scintigraphy method to verify this semi-empirical model, the model was found to show 
excellent accuracies of around 97% and a prediction error of only 3% (Fiore et al., 2006). 
In addition to the mathematical model, methods for performing indirect measurements of 
the internal filtration have also been proposed. Changes in non-permeable molecular 
concentrations occur in response to the water content of blood, and thus, the kinetics of 
water transport across membrane can be evaluated by measuring the cumulative 
concentration changes of non-permeable molecules (Ronco et al., 1992). Radiolabeled 
albumin (a non-permeable molecule) has been employed to determine the amounts of 
convection for hemodialyzers with reduced fiber diameters or an obstacle in dialysate 
stream (Ronco et al., 2000, 1998). A series of in vitro experiments proved that this 
scintigraphic method was accurate for measuring internal filtration rates, but despite its 
precision, its clinical application is not plausible due to the safety issue raised by the use of 
radio-labeled molecules and the complexities of the procedures and equipment. 
Another approach to determine internal filtration is offered by Doppler ultrasonography, 
which measures changes in blood velocity within dialyzers. In the absence of net-filtration, 
blood volume depletion in the proximal portion of a hemodialyzer leads to a reduction in 
blood flow velocity, and after the lowest point has been reached, the blood velocity 
gradually increases due to backfiltration. Thus, changes in blood velocity along a dialyzer 
provide information on blood volume changes and on amounts of forward and backward 
filtration. In one study, the internal filtration rate of a 250 mm dialyzer was found to be 37.7 
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ml/min by Doppler ultrasonography, but only 11.1 ml/min for a standard 195 mm dialyzer 
(Sato et al., 2003). Doppler ultrasonography is straightforward, non-invasive, and easily 
used at bedside (Mineshima, 2011). However, the method is still incapable of measuring 
blood flow velocity precisely, particularly blood velocity deep within the membrane fiber 
bundle. In other words, this method is based on velocities measured in peripheral 
membranes, which are quite different from velocities within centrally located fibers, and as 
a result, deviations from true values are unavoidable. 
Other techniques have also been explored in an effort to quantify the filtration phenomena, 
or to visualize flow distributions inside hemodialyzers, these techniques include magnetic 
resonance imaging (Hardy et al., 2002), computed tomography (Frank et al., 2000, J. C. Kim 
et al., 2008) and a computerized scanning technique (Ronco et al., 2000, 2002). However, the 
quantification of internal filtration using these techniques is not available clinically, due to 
concerns of patient safety and technical requirements. 
Summarizing, internal HDF can provide a means of convective treatment by increasing 
internal filtration rates using specifically designed hemodialyzers, and at the same time 
spontaneous backfiltration compensates for fluid loss, and hence, this technique is simpler 
than other modalities. The hemodialyzer design for internal HDF must be optimized based 
on specified structural factors and on the filtration characteristics of membrane fibers. The 
literature suggests superior dialysis outcomes for iHDF, but the precise quantification of 
internal filtration remains to be determined. 
2.2 Double high-flux HDF 
Solute removal during extracorporeal hemodialysis, particularly for low-flux HD, is mainly 
facilitated by diffusion which is driven by the concentration gradient across membrane. 
Thus, solute clearances are highly dependent on their molecular weights. On the other hand, 
hemofiltration (HF) is purely convective. Thus, it could be speculated that HF delivers 
higher middle- to large-size solutes clearances than HD, but poorer small-size mass transfer. 
The additional advantages of this convective treatment include better maintenance of 
cardiovascular instability in ESRD patients or in ICUs. These benefits of hemofiltration 
encouraged investigations aimed at compensating for the inferior diffusive clearances of HF, 
and a hybrid configuration based on multiple membranes was introduced (Cheung et al., 
1982). 
Double high-flux HDF was first introduced in the early 1980’s as a means of combining HD 
and HF. This technique was particularly aimed at significantly increasing small (diffusion) 
and middle-size molecular removal (convection) in order to shorten overall treatment time, 
and therefore, much larger surface areas were used by arranging two high-flux 
hemodialyzers in series, in conjunction with a extremely high blood (400-500 ml/min) and 
dialysate flow rate (800-1000 ml/min) and a bicarbonate dialysate (Miller et al., 1984, von 
Albertini et al., 1984). 
This arrangement of two hemodialyzers enabled flow resistances through the two 
hemodialyzers to be manipulated, which permitted TMP gradients (both positive and 
negative) to be adjusted. A flow restrictor, placed on the intermediate blood line of two 
hemodialyzers, serves as a means of increasing blood pressures in the arterial-side 
hemodialyzer, which cause positive TMPs through this dialyzer and ultrafiltration (Fig. 2). 
On the other hand, blood pressure drops below dialysate pressures at the venous-side 
dialyzer and TMPs become negative, which leads to backfiltration (Shinzato et al., 1982). 
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Fig. 2. Schematic Pressure Profiles during Double HDF, when a flow restrictor is placed on 
blood tube (upper) and on dialysate tube (below) of the two hemodialyzers. 
TMP regulation is also achieved by regulating dialysate pressure. Flow resistance applied to 
the dialysate tubing between the two dialyzers promptly increases dialysate pressures at the 
venous dialyzer because blood and dialysate flow in opposing directions. Hydraulic 
dialysate pressures exceed blood pressures, which leads to backfiltration in the venous 
dialyzer. However, dialysate pressures rapidly fall in the arterial dialyzer due to flow 
restriction, which causes ultrafiltration in the arterial dialyzer. In addition, the high blood 
and dialysate flow rates used are also associated with larger pressure gradients. Hence, 
ultrafiltration at the arterial dialyzer at levels of exceeding those required can be promptly 
compensated for by backfiltration at the venous dialyzer, and thus, exogenous replacement 
infusion is not required for this method. 
The flow resistance placed on the dialysate stream was originally made from a gauge needle 
assembled with a bypass line in parallel. A clamp on the bypass line forced the dialysate 
into the gauge needle, and created flow resistance in dialysate stream. The flow resistance in 
this configuration is fixed, and the amounts of ultrafiltration and backfiltration cannot be 
adjustable externally. Hence, the means of creating resistance to dialysate flow was 
improved in the advanced version, termed convection-controlled double high-flux HDF, in 
which variable and controllable flow resistances were integrated (Pisitkun et al., 2004).  
Therefore, together with these features, this modality achieved unmatched depurative 
outcomes, as demonstrated by far higher uremic molecular clearances regardless of 
molecular size (Cheung et al., 1982, Shinzato et al., 1982, von Albertini et al., 1985). 
Furthermore, increased clearances allowed treatment times to be shortened (Miller et al., 
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1984, von Albertini et al., 1984). Solute removal in a relatively short time (e.g., 2 hours) may 
cause greater rebound of uremic solute levels after post-dialysis equilibrium, thus solute 
removal rates in trials of double HDF far surpassed the removal rates desired during 
hemodialysis, achieving two and half times higher clearances over 2 hours as was achieved 
over 4 hours in conventional HD mode. These results were also confirmed by comparing 
treatment modalities. Double high-flux HDF attained significantly greater ǃ2M reduction 
and Kt/VUREA values than high-flux HD, and showed comparable ǃ2M clearance to that of 
on-line HDF (Susantitaphong et al., 2010, Tiranathanagul et al., 2007). Furthermore, the 
beneficial effect of this technique on patient survival was also suggested in a long-term 
assessment. In this study, double high-flux HDF was compared with high-efficiency or high-
flux HD modes in terms of treatment time, Kt/V and standardized mortality ratio over 6 
years. Kaplan-Meier Survival analysis revealed a significantly lower mortality ratio for 
double HDF versus USRDS (0.41 and 1, respectively) despite the shortened treatment time 
(Bosch et al., 2006). 
However, concerns have been raised regarding the use of two hemodialyzers in this double 
HDF technique, such as, possible increases in treatment cost and system complexity. One 
possible way of overcoming these issues involves the reuse of dialyzers, although regulatory 
guidelines on renal replacement practices in some countries do not permit reuse. Another 
concern arises from the large amount of cross-membrane flux. In particular, a large quantity 
of backfiltration should be assured by the strict and regular verification of water quality 
(Bosch & Mishkin, 1998), although this too could increase treatment-related costs. One 
positive aspect is that the venous dialyzer acts as a final barrier to pyrogen transfer. 
Double high-flux HDF emerged as a result of an effort to increase treatment efficiencies and 
shorten treatment times by maximizing both diffusive and convective mass transfer. Many 
observations have confirmed the high solutes clearances across a wide spectrum of 
molecular weights, which are the results of the unique features of this method. In particular, 
the unique control of hydraulic pressures possibly gives this unit the ability to regulate 
convective dose. However, the widespread implementation of this technique may require 
the identification of patients capable of tolerating treatment and the overcoming of the 
above-mentioned underlying concerns. 
2.3 Paired filtration dialysis with endogenous reinfusion (HFR) 
Another two-chamber technique for obtaining short and efficient HDF treatment is the so-
called paired filtration dialysis (PFD). Like double HDF, PFD is also a strategy of 
simultaneous HD and HF treatment aimed at increasing both diffusive and convective 
clearances, but its design principles separate convection from diffusion (Ghezzi et al., 1989, 
1987, Ronco et al., 1990). A hemofilter with a relatively small surface area is combined with a 
hemodialyzer in this sequence (Fig. 3). Ultrafiltration purely occurs at the hemofilter and 
then blood is dialyzed continually through the hemodialyzer. 
The convection, which is not connected with diffusion, can minimize interactions between 
diffusion and convection, and enable the precise quantification of convective clearance 
(Ghezzi et al., 1987). Total resulting clearances during HDF are always lower than the sum 
of convective and diffusive clearances, which is attributed to the reciprocal interactions of 
these two processes (Gupta & Jaffrin, 1984, Sprenger et al., 1985). As diffusion and 
convection occur within the same membranes, the contribution made by convection to total 
clearances is diminished by the presence of diffusion, particularly for highly diffusive 
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Fig. 3. PFD (left) and HFR (right) 
molecules. This is because the concentrations of these molecules promptly decreases along 
the dialyzer length due to diffusion, and in this situation, solute concentrations in 
ultrafiltrate are reduced. Likewise, diffusive mass transfer is also disrupted by the presence 
of convection. High filtration rates throughout the entire membrane causes the formation of 
protein gel layer, which acts as secondary resistance; that is, the membrane fouling 
decreases membrane permeability and filtration rates, and consequently, convective 
clearances are substantially diminished. Furthermore, molecular sieving coefficients are also 
reduced because of protein binding, which eventually reduces membrane diffusivity (Morti 
& Zydney, 1998). In the PFD technique, however, convection occurs in a separate region 
from diffusion and theoretically, no interference between diffusion and convection occurs. 
In addition, independent convection allows ultrafiltrate volume to be regulated. The total 
amount of ultrafiltration surpasses desired volume removal, and sterile replacement fluid is 
administered at the mid-point between the hemofilter and hemodialyzer shown in the Fig. 
3. In addition, desired net-volume removal by PFD can be achieved either by balancing 
ultrafiltration and reinfusion through the hemofilter, or by balancing internal filtration in 
the hemodialyzer.  
Likewise, as for other convective treatments, simultaneous but separate convection of PFD 
permitted higher depurative outcomes than standard HD mode, and even allowed 
treatment times to be reduced (Vanholder et al., 1991). Dialysis times could be reduced to as 
little as 150 minutes per session in patients with a body weight of < 61 kg, but normally 3 
hours was required for larger patients, without compromising dialytic tolerance and 
efficiency (Botella et al., 1991). PFD also achieves dialytic efficiencies comparable with HDF 
despite significantly lower filtration rates (40 versus 75 ml/min, respectively) (Bufano et al., 
1991), which is primarily due to minimal interference between diffusion and convection. 
However, ǃ2M removal is smaller than in HF mode (Marangoni et al., 1992). Other benefits 
of PFD may include the minimal use of backfiltration in the hemodialyzer and superior 
biocompatibility (Panichi et al., 1998). Since convection is achieved at the hemofilter, dialysis 
can be accomplished with minimal internal filtration and pressure gradients.  
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However, PFD obviously requires the exogenous substitution infusion because of larger 
amounts of ultrafiltrate than required volume removal. One unique feature of PDF is that 
the ultrafiltrate is not mixed with the dialysate. In addition, the ultrafiltrate has a similar 
composition of plasma. On the other hand, the replacement fluid must possess a physiologic 
balance of electrolytes after taking into account preexisting deficits or excesses, and also 
should be sterile and free of pyrogenic substances. These features of ultrafiltrate and 
infusate enables the regeneration of ultrafiltrate to replace exogenous infusate, and 
ultrafiltrate for replacement purposes was successfully regenerated using an uncoated 
charcoal column (Ghezzi et al., 1991, 1992) (Fig. 3). As ultrafiltrate passes through the 
adsorbent column, solutes with a wide spectrum of molecular weights are adsorbed with 
the exception of some small molecules (e.g., urea and phosphate), but electrolytes and 
bicarbonate freely pass through the column. In addition, since small molecules that are not 
captured by the adsorbent can be removed by diffusion at the hemodialyzer, the 
regenerated ultrafiltrate is successfully applied as replacement fluid (Sanz-Moreno & 
Botella, 1995). Trace elements, such as manganese, selenium, arsenic, cadmium, mercury, 
lead, chromium, and zinc, also remain unaltered after passing through the adsorbent 
column, whereas copper is completely retained by the charcoal (de Francisco et al., 1997). 
Adsorption capacities were further increased by combining hydrophobic styrenic resin 
along with uncoated charcoal, because the resin has a high binding affinity for several mid 
molecular weight species, such as, ǃ2M (Marinez de Francisco et al., 2000) and homocysteine 
(Splendiani et al., 2004), or free immunoglobulin light chains (Testa et al., 2010). 
The other benefits of this regenerated ultrafiltrate include a better acid-base balance due to 
the reinfusion of endogenous bicarbonate (de Francisco et al., 1997), and also the not 
inconsiderable advantage of combining high convection without compromising physiologic 
molecule loss. Ultrafiltrate has a composition similar to that of plasma and contains huge 
numbers of polypeptides and other beneficial substances, such as, hormones, amino acids, 
and vitamins (Weissinger et al., 2004), and ultrafiltrate regeneration allows these beneficial 
nutrients to be reinfused (La Greca et al., 1998). In terms of plasma amino acid levels, no 
significant changes in their intradialytic levels occur during HFR, whereas a ~25% reduction 
occur during acetate-free biofiltration (Borrelli et al., 2010). 
A number of clinical studies on ESRD patients have revealed that HFR remarkably improve 
dialytic efficiencies and solute removal over a wide molecular weight ranges, such as, the 
removal of uremic marker molecules (ǃ2M, leptin and free immunoglobulin light chains) 
(Bolasco et al., 2006, S. Kim et al., 2009, Testa et al., 2006), cardiovascular risk factors 
(homocysteine) (Splendiani et al., 2004), inflammatory cytokines (CRP, IL-1, IL-6), and 
biomarkers of oxidative stress (ox-LDL, IL-1ǃ) (Calo et al., 2011, Testa et al., 2006). In a 
comparison between HFR and on-line HDF, both were found to be highly biocompatible 
and to considerably reduce inflammatory markers, such as, CRP and IL-6 (Panichi et al., 
2006). One technical variance of HFR is the repositioning of convection and diffusion. The 
change of sequence during HFR significantly enhanced reductions in urea and ǃ2M, 
possibly due to the less saturated use of adsorbents, and also reduced cytokine levels, e.g., 
IL6 and TNFǂ, more than conventional HFR (Meloni et al., 2004, 2005).  
In addition, HFR appears to be more beneficial at reducing oxidative stress and the risk of 
atherosclerotic cardiovascular disease than standard HD mode. A comparative study of 
HFR and low-flux bicarbonate HD revealed that HFR reduced not only the plasma level of 
oxidized low-density lipoprotein (LDL), but also the mRNA production of p22phox and 
PAI-1 (palsminogen activator inhibitor 1), whose protein expressions are known to be 
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closely related to inflammation and oxidative stress (Calo et al., 2007). Furthermore, plasma 
total antioxidant capacity (TAC) and antioxidant enzymes activities were found to be lower 
for HFR than high-flux HD (Gonzalez-Diez et al., 2008).  
However, contrary results have also been presented. For ESRD patients who undertook 
bicarbonate HD and then were switched to HFR, nutritional and inflammatory parameters 
remained unchanged over a year. Neither serum ǃ2M nor PTH levels varied over the course 
of time, which led to the conclusion that although the change to HFR from bicarbonate HD 
is safe and tolerated, it is not associated with an improvement in nutritional or 
inflammatory parameters, or a reduction in ǃ2M levels (Bossola et al., 2005). Prolonged, 
larger-scale clinical studies for HFR are warranted. 
More recently, a significant decrease was observed in cardiac troponin (cTnT) levels, a 
marker of myocardial damage and cardiac hypertrophy, throughout HFR sessions when 
using acetate-free dialysate, but cTnT increased after HFR using dialysate containing 
acetate. These results show that further explanation is required for the correlation between 
cTnT and acetate (Bolasco et al., 2011). However, both hemoglobin (Hb) levels and 
erythropoietic-stimulating agent (ESA) doses were not related to the presence of acetate. Hb 
levels increased, but ESA requirements tended to reduce continually during the 9-month 
study period (Bolasco et al., 2011).  
In summary, PFD is a HDF technique whereby ultrafiltrate is isolated from dialysate. Renal 
replacement therapies, facilitated by convection and diffusion, are still unsatisfactory for 
removing uremic toxins, and thus, adsorption as a third mechanism has been employed in 
HFR units. Adsorption during HFR allows convective treatments to be performed by the 
endogenous reinfusion of ultrafiltrate. Even if the loss of beneficial substances during HDF 
is inevitable, ultrafiltrate reinfusion reduces these losses to a minimum, like low-flux HD. 
Another feature of ultrafiltrate regeneration is the guaranteed purity of substitution fluid. 
Substitution is continuously obtained from ultrafiltrate, but the ultrafiltration, adsorption, 
and reinfusion system is totally closed during HFR, and therefore, excludes any possibility 
of contamination and ensures superior biocompatibility. However, despite these 
outstanding features, this unit has complications and associated costs. Furthermore, 
technical improvements in the preparation of ultrapure dialysate are expected to further cut 
the cost of preparing sterile, ultrapure replacement fluid, and this could increase the cost 
gap between HFR and on-line HDF. 
2.4 Push/Pull Hemodiafiltration 
A similar but simpler HDF strategy has been also introduced. This system relies on alternate 
repetitions of forward and backward filtration during dialysis treatment, and thus, it was 
named push/pull HDF. When the infusion-free HDF technique using a serial arrangement 
of two hemodiafilters was described in the early 1980’s, the push/pull concept was devised 
to eliminate the need for two hemodiafilters. It is obvious that repetitive ultrafiltration can 
increase total filtration volume, but such a system also requires a means of repeating 
backfiltration (Usuda et al., 1982). Thus, a redundant dialysate bag is integrated 
downstream of the hemodialyzer, which is connected to the dialysate stream by a 
bidirectional peristaltic pump. The push/pull action that is accomplished by this bi-
direction pump is responsible for alternating the evacuation and replenishment of the bag. 
During normal operation, inlet and outlet dialysate flow rates are equally maintained and 
the desired volume removal is achieved by a separate ultrafiltration pump. In this situation, 
when the bidirectional pump pulls a portion of dialysate into the bag (70 ml/min for 3 
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minutes), hydrostatic pressures through the dialysate compartment decrease, because the 
dialysate compartment is closed and has a fixed volume, and water flux occurs from blood 
to the dialysate compartment (ultrafiltration) at the same level as dialysate removal from the 
dialysate compartment. Soon after the ultrafiltration completes, the pump operates in 
reverse and pushes the dialysate in the bag into the dialysate stream, which causes a volume 
overload in the dialysate compartment. The surplus dialysate in the closed dialysate 
compartment is then moved to the blood compartment (backfiltration). In the same manner, 
another bag and an additional bidirectional peristaltic pump is also integrated into the 
venous chamber, and conducts the pulling and pushing of blood, although in this case, the 
actions of the blood-side pump are 180O out of phase with those of the dialysate side pump 
to keep blood flow returning to the patient constant. 
When pure dialysate is pushed into the blood stream, solute concentrations in blood are 
immediately equilibrated and decreased by dilution. Soon after, the blood-to-dialysate 
pressure gradient reverses from negative to positive, and plasma fluid in blood is forced to 
move into the dialysate compartment, which removes various molecules from plasma. This 
repetitive ultrafiltration obviously contributes to convective mass transfer and increases the 
reductions of small-sized (urea) or mid-sized (ǃ2M) molecules as compared with HF or HD, 
respectively (Shinzato et al., 1989). On the other hand, repetitive backfiltration during 
push/pull HDF prevents volume depletion. In addition, the repetitive backflushing of 
dialysate also helps prevent membrane binding (Usuda et al., 1982). 
However, disposable bags and separate bidirectional peristaltic pumps make this unit 
complicated and increase treatment costs. Instead, a double-chamber cylinder pump was 
devised with two independent chambers and a reciprocal piston; that is, each chamber is 
connected to either dialysate or the blood stream (Tsuruta et al., 1994), as seen in Fig. 4. 
When the piston squeezes the chamber on the dialysate side, the dialysate compartment, 
which has a fixed volume, is pressurized and backfiltration begins. At this time, the chamber 
on the blood side expands and blood in the venous chamber starts flowing in the direction 
of the double-chambered pump. Since the blood volume that returns to the blood-side 
chamber of the pump is equal to the backfiltration volume, blood flow returning to patients 
remains constant. The piston then moves in the opposite direction and squeezes the blood-
side chamber, the dialysate compartment begins to expand, and the dialysate compartment 
becomes depressurized, which leads ultrafiltration. However, despite the large amount of 
ultrafiltration, blood flow in the venous line is maintained, because the ultrafiltrate removed 
in the hemodialyzer is replenished in the venous chamber. 
Furthermore, the reciprocating movement of the piston is regulated by pressure differences 
between the two chambers of the cylinder pump (i.e., Pb-Pd). The rotation torque of the 
driving motor attached to the piston can be expressed in accord with TMP (i.e., torque = 
TMPxSxLxsinθ). Voltage applied to the motor is adjusted so that the TMP is set at 400 
mmHg during forward filtration, but at -400 mmHg during the backward filtration phase, 
that is, pressure-controlled push/pull HDF can maintain transmembrane pressures at the 
maximum permissible level throughout treatment (Shinzato et al., 1994). In addition, 
contrary to the original push/pull HDF, in which one cycle of filtration and backfiltration 
takes approximate 4~5 minutes, the pressure controlled push/pull HDF unit can repeat one 
cycle in1.5~1.7 seconds.  
This optimized use of transmembrane pressure and more frequent alternations of forward 
and backward filtration in the revised push/pull HDF unit are obviously accompanied with 
a markedly larger total filtration volumes and higher solutes clearances (Shinzato et al., 
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1994). Push/pull HDF tends to relieve symptoms like arthralgia (joint pain), irritability, 
pruritus, and insomnia more rapidly than conventional HD (Maeda et al., 1990, Maeda & 
Shinzato, 1995, Shinzato et al., 1995). Furthermore, the optimal maintenance of membrane 
permeabilities by prompt backfiltration has the added benefit of considerably inhibiting 
albumin loss in addition to increasing convection and diffusion (Shinzato et al., 1996). 
Albumin loss is inevitable when using membranes with high water permeabilities and sieving 
characteristics (Combarnous et al., 2002). Since convective therapy is based on larger amounts 
of fluid exchange and solvent drag during fluid exchange occurs randomly, albumin 
permeation becomes more worrisome during convective treatments (Ahrenholz et al., 2004). In 
addition, filtration-induced elevated albumin concentration at the inner membrane wall also 
aggravates the albumin loss (Miwa & Shinzato, 1999). Protein concentration polarization 
develops quickly after sudden TMP development and the hydraulic permeabilities of the 
membrane decrease rapidly in about 2 seconds. However, during push/pull HDF, backward 
flushing of dialysate takes place within the time frame required for the protein layer to fully 
develop (i.e., 1.5~1.7 seconds), and thus, it can effectively wash out the inner lumen and inhibit 
excessive albumin leakage (Shinzato et al., 1996). 
However, this modality still requires the use of a separate device so that dialysate pressures 
are regulated instantaneously. In addition, no clinical observation has been conducted to 
examine the long-term clinical effect of pressure-controlled push/pull HDF versus on-line 
HDF, which is now regarded as a convective therapy in dialysis practice. Push/pull HDF is 
based on repetitive dilution at a rate of approximate 15 ml per 1.7s cycle, which exceeds 
blood flow rates (3.3~5 ml/s). Hence, push/pull HDF is assumed to be close to pre-dilution 
mode HDF (Shinzato & Maeda, 2007). Even though post-dilution HDF is more efficient in 
terms of solute removal, the substantial amount of total filtration and the optimal use of 
membrane offered by the push/pull HDF technique probably translate to outstanding 
hemodialytic outcomes. 
Push/pull HDF was developed in an effort to perform infusion-free, simultaneous HD and 
HF by using a single hemodialyzer. Thus, it alternates between forward filtration and 
backfiltration instead of dividing ultrafiltration and backfiltration regions. Pressure-
controlled push/pull HDF using a double-chambered cylinder pump can maintain TMPs at 
maximal levels and the total filtration volumes achieved are far greater than that of any 
other treatment modality. In addition to the filtration quantity, repetitive cycles in a shorter 
time than the time required for a protein layer to be established ensure superior membrane 
use throughout treatment, which further inhibits albumin loss. However, given the 
advances represented by membranes with high ǃ2M sieving coefficients (>0.8), but very 
small albumin sieving coefficients (<0.01) (Ronco et al., 2002), the differences between 
push/pull HDF and high-flux HD with respect to ǃ2M removal may be reduced, and 
albumin leakage less problematic. To an extent in modern dialysis practice, albumin 
permeable membranes are even considered to remove non-soluble and/or much larger 
molecules (De Smet et al., 2007, Samtleben et al., 2003). Therefore, a prolonged prospective 
study on push/pull HDF may be worthwhile to determine the benefits of this modality 
versus other forms of convective renal replacement. 
3. Pulse Push/Pull Hemodialysis (PPPHD) 
Flow patterns, that is, pulsatile versus non-pulsatile, remain topics of research for treatments 
requiring extracorporeal blood circulation. Despite controversy, blood pulsation has been 
www.intechopen.com
 Progress in Hemodialysis – From Emergent Biotechnology to Clinical Practice 
 
126 
accepted to have a benefit during cardiopulmonary bypass, because it achieves greater 
perfusion to peripheral vessels and end-organs (Dapper et al., 1992, Orime et al., 1999). 
Furthermore, blood pulsation in a pediatric CRRT1 animal model was found to deliver 
adequate performance over a 2-hour period in terms of ultrafiltration rates and cross-filter 
blood pressure drops (Lopez-Herce et al., 2006, Ruperez et al., 2003). In addition, it was also 
found that the pulsatile flow tends to enhance ultrafiltration rates versus non-pulsatile flow 
(Lim et al., 2009, Runge et al., 1993), which attributed to an increased rheological power of 
pulsatile flow. However, little clinical or experimental evidence is available that explains the 
efficacy of pulsatile flow during dialysis. Pulse push/pull HD is a convection enhanced 
dialysis treatment, based on the use of pulsatile flows to achieve a cyclic repetition of 
forward and backward filtration. As explained in the previous section, the repetitive manner 
of ultrafiltration and backfiltration contributes substantially to total volume exchange and 
convective mass transfer. 
 
 
Fig. 5. T-PLS pump for the original PPPHD 
3.1 Pulse push/pull HD 
Repetitive procedures of ultrafiltration and backfiltration during PPPHD are achieved by 
replacing conventional roller pumps with pulsatile pumps for both blood and dialysate. 
During an early trial, a T-PLS pump (Twin Pulse Life Supporter, AnC Bio Inc., Seoul, Korea) 
was used as pulsatile pumps for blood and dialysate (K. Lee et al., 2008). The T-PLS consists 
of blood and dialysate sacs, a reciprocating actuator, and a motor-cam assembly (J. J. Lee et 
al., 2005). The actuator is located between blood and dialysate sacs (Fig. 5). When the 
actuator squeezes the blood sac, blood in the sac can move only in the forward direction due 
to the presence of one-way check valves. At the same time, the dialysate sac expands and is 
filled with fresh dialysate. In the same manner, dialysate also moves forward when the sac 
is squeezed, and these reciprocating movements create pulsatile flow. By setting their phase 
difference at 180O degrees, the respective pushing phases of blood and dialysate pumps 
                                                 
1 Continuous Renal Replacement Therapy   
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alternate, and TMPs cycle between positive and negative, which drive consecutive periods 
of ultrafiltration and backfiltration. 
The hemodialytic efficiencies of PPPHD have been demonstrated in vitro and also in vivo, 
and these studies have shown that PPPHD substantially improves the clearances of uremic 
marker molecules, particularly for mid-sized molecules (Table 1) (K. Lee et al., 2008), which 
is believed to be due to a higher level of total filtration. Pressure profiles also showed 
obvious oscillations of TMPs throughout treatment, and their magnitudes were significantly 
larger than those observed in conventional hemodialysis (CHD) mode.  
 
Group BPM QB QD 
Clearance (ml/min) 
BUN Creatinine Vitamin b12 Inulin 
CHD - 236±3.6 420±3 161.1±4.3 127.2±3.9 37.5±6.3 25.3±5.1 
PPPHD 40 234±3.1 419±3 166.2±3.8 136.9±4.2 55.7±5.0 37.8±3.9 
% Increase  - - 3.2 7.6 48 49 
P-value  NS NS 0.053 <0.05 <0.001 <0.001 
Table 1. Solutes Clearances. (CHD, conventional high-flux HD; PPPHD, pulse push/pull 
HD; BPM, beats per minute; QB, blood flowrate; QD, dialysate flowrate; BUN, blood urea 
nitrogen; NS, not significant) 
Increased filtration volumes in the PPPHD unit may also be due to reduced membrane 
fouling. In an in vivo setup on PPPHD, one cycle of ultrafiltration and backfiltration took 3 
seconds at a pulse frequency of 20 bpm (K. Lee et al., 2008). When ultrafiltration and 
backfiltration times were defined as the durations of positive and negative TMPs, 
respectively, ultrafiltration and backfiltration times for the PPPHD unit were 1.68±0.02 and 
1.31±0.03 seconds, respectively. Since protein concentration polarization on the blood-side 
membrane develops during the forward filtration phase and it is reduced by backfiltration, 
membrane convective capacity might be better maintained during PPPHD than during 
CHD, showing smaller reductions in post-dialysis hydraulic permeabilities (K. Lee et al., 
2008). Furthermore, PPPHD-treated animals were tolerably sustained and their physiologic 
parameters were stable. 
Pulse push/pull HD is conceptually similar to push/pull HDF. Both modalities were 
devised to increase total filtration level by alternating forward and backward filtration. 
However, the underlying design of PPPHD differs from push/pull HDF, and thus, the 
supplementary component required to switch from ultrafiltration to backfiltration phases or 
vice versa used in push/pull HDF was eliminated for PPPHD and the entire system was 
remarkably simplified. 
3.2 Modification of PPPHD 
Repetitive ultrafiltration and backfiltration offers a simple and efficient HDF strategy. 
However, the pulsatile circulation of blood during extracorporeal renal replacement 
treatment appears to be potentially problematic. In particular, instant suction generated by a 
pulse pump through a narrow needle or catheter may cause blood damage, vessel 
narrowing, or vessel collapse. In addition, instantaneous negative pressures generated 
upstream of a pulsatile blood pump not only introduce the risk of circuit aeration, but also 
lead to a failure to maintain predetermined blood flow rates (Depner et al., 1990, Teruel et 
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al., 2000). Furthermore, the quantification of accurate filtration rates throughout treatment 
remains implausible. 
 
 
Fig. 6. Dual Pulse Pump (DPP). Its body is made of an aluminum alloy, and comprises a 
base plate, a unidirectional electric motor (not seen), a cam, and four actuators. It can also 
contain two separate silicone tubes. Pulsatile flow is generated by squeezing each dialysate 
and effluent tubing segments. (A1~A4, actuators 1 to 4; p1~p6, silicone tubing segments at 
positions 1 to 6, respectively) 
Hence, we revised PPPHD and many aspects of the original PPPHD were retained in the 
revised version, including an alternating water flux across the membrane, but blood 
pulsation was excluded. This was achieved by employing dual pulsation in the dialysate 
stream, that is, pulsatile devices in the dialysate stream both upstream (a dialysate pump) 
and downstream (an effluent pump) of the dialyzer. Backfiltration occurs when the sum of 
the cross-membrane pressures is negative, but ultrafiltration when the sum is positive. The 
hydraulic pressures of blood and dialysate were both manipulated in the original PPPHD, 
but since blood pulsation was eliminated, the dialysate pressure is the only variable that 
regulates TMP in the revised unit. Therefore, an assumption was made; (1) dialysate 
compartment pressures must be far higher than blood-side pressures when pure dialysate is 
forced into the dialyzer (that is, when the dialysate sac is squeezed), but (2) dialysate 
pressures drop to lower than blood pressures during effluent pump expansion. For this 
purpose, the dialysate and effluent pumps are replaced with a dual pulse pump (K. Lee et 
al., 2008). 
The dual pulse pump (DPP) is a pulsatile device that was developed to eliminate the one-
way valves that are generally required for pulsatile devices to prevent retrograde flow; 
instead, time-delayed tube openings and closings constitutes a cycle of pulse generation 
(Fig. 6). In other words, two separate silicone tubes in the DPP are periodically opened or 
closed. Pulse generation with DPP can be described in terms of four phases as determined 
by cam rotation, which translates motor rotation to actuator linear displacement. As the cam 
rotates, the four actuators periodically push on the tubing segments at the positions shown 
in the Fig. 6. Actuator 1 pushes on the tubing segments at positions 1 and 6 (p1 and p6) 
simultaneously, and actuator 3 squeezes the tubing segments at positions 3 and 4. Actuators 
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Fig. 7. Tube Openness Diagram for Dialysate (upper) and Effluent Pump (below) of DPP. 
2 and 4 squeeze tubing segments at p 2 and p5, respectively, and caused the dialysate in the 
tube to move in the required direction. The first phase was defined as a cam rotation angle 
(θ) between 0 and 90°. Likewise, the 2nd and 3rd phases were defined as cam rotation angles 
between 90°~180° and 180°~270°, respectively. For pulse generation by the dialysate pump, 
as the cam rotates from θ=0° to 90°, the p2 tubing segment opens and p1 closes, and these 
processes overlap such that pure dialysate fills p2 tubing. While p2 expands, p3 remains 
closed, acting as an upstream valve to prevent retrograde dialysate. These tube openings 
and closings are also depicted in the tube openness diagram in Fig. 7. Tube openness is 
defined as the ratio of compressed tube diameter to the original internal diameter, as 
described elsewhere (K. Lee et al., 2008). During the first phase, with p3 closed, p2 tube 
openness increases whereas p1 tube openness decreases. During the 2nd phase 
(θ=90°~180°), with p1 closed, p2 begins to be squeezed and simultaneously p3 begins to 
open, and pure dialysate is driven into the hemodialyzer. Closure of p1 fulfills the same 
function as atrioventricular valve closure during left ventricular systole, which prevents 
retrograde flow. During the 3rd phase (θ=180°~270°), p3 is closed, while p1 and p2 remain 
closed and in the final phase (θ=270°~360°), p1 is open, and p2 and p3 remain closed in 
preparedness for the next filling phase. These time-delayed tube openings and closures 
constitute one cycle of pulse generation. In the same manner, effluent pulsations were also 
generated through the effluent tube, although in this case, the actions of actuators 1 and 3 
were reversed, and the pulsatile flow pattern was 180O out of phase with that in the 
dialysate tube. 
Theoretically, forward and backward filtration rates during one cycle of PPPHD are 
identical to effluent and dialysate flow rates, respectively. The moment when pure dialysate 
is driven to the dialyzer (i.e., during p2 squeezing), the effluent dialysate path is closed at 
p6. At the same time, p1 is also closed, and thus, the pure dialysate pushed into dialyzer 
should move into the blood stream (backfiltration), because the whole dialysate 
compartment is fixed and closed. Immediately after the backfiltration is completed, the 
effluent tubing (p5) begins to expand (i.e., p5 expansion), and since the dialysate and 
effluent pathways are still closed at p1 and p6, respectively, dialysate pressures in the 
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hemodialyzer drop steeply and ultrafiltration takes place at a rate determined by effluent 
stroke volume. 
During animal experiments using the PPPHD, in which we used an acute canine renal 
failure model (achieved by ligating renal arteries and veins), the animals remained stable 
without any procedurally related complications. Molecular removals were satisfactory, and 
total protein levels, albumin concentrations, and glucose levels were preserved uniformly 
throughout PPPHD sessions (Table 2). Furthermore, TMPs clearly cycled positive and 
negative due to huge fluctuations in hydraulic dialysate pressures (Fig. 8). In addition, 
despite the use of a peristaltic roller pump for blood, the blood pressures acquired during 
PPPHD showed an obvious fluctuation which was perfectly synchronized with dialysate 
pressure pulsation. Generally, peristaltic roller pumps create small fluctuations in flow and 
pressure, because of the way they squeeze tubing. However, the blood pressure fluctuations 
acquired during PPPHD were much larger than that observed for conventional HD, which 
provides evidence of dialysate flux to the blood stream or vice versa (Fig. 8). 
In addition, as stated before, the DPP is characterized by a lack of valves, which makes the 
pulsatile device simple and inexpensive, and thus, any medical-grade silicone tubes can be 
used as dialysate and effluent sacs. Furthermore, with the exception of small tubing sections 
at p1, p3, p4, and p5, most of the tubing is operated non-occlusively, which reduces the 
probabilities of tubing rupture and spallation (W. G. Kim & Yoon, 1998, Leong et al., 1982). 
 
PPPHD 
(h) PCV TP ALB Glu Ca2+ Na+ K+ BUN Crea 
0 28.5±4.6 5.3±0.4 3.1±0.1 119±7 12.4±0.8 136±5.7 5.7±0.6 90.3±12.7 6.5±0.9 
2 28.0±3.6 5.6±0.7 3.1±0.2 111±4 11.5±0.8 134±4.2 5.1±0.6 63.7±5.7 4.6±0.7 
4 27.3±3.5 5.3±0.4 3.1±0.2 126±44 10.8±0.5 132±3.1 4.3±0.5 47±7.2 3.8±0.4 
Table 2. Animal Experiment Results. PCV, packed cell volume (%); TP, total protein (g/dl); 
ALB, albumin (g/dl) ; Glu, glucose (mg/dl); BUN, blood urea nitrogen (mg/dl); Crea, 
creatinine (mg/dl) 
 
 
Fig. 8. Pressure Profiles during PPPHD treatment (upper), and Changes in Blood Pressures 
for PPPHD and CHD (below). (MDP, mean dialysate pressure; MBP, mean blood pressure; 
CHD, conventional HD) 
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3.3 Fluid management in PPPHD 
Recently, the dual pulsatile pump integrated into the dialysate stream has been remarkably 
ameliorated to achieve a substantial increase in the accuracy of volume control. Maintaining 
pre-determined flow rates and precise volume control are pre-requisites of extracorporeal 
renal replacement treatments for ESRD patients, particularly when using membranes with 
high-water permeability. Therefore, the dual pulsation system acting on the PPPHD 
dialysate compartment was replaced with a dual piston pump, as shown in Fig. 9. This 
modification allows pulse generation and push/pull to be achieved, not only by the novel 
design of the piston pump, but also by the unique control of piston movements offered (Fig. 
10). As the dialysate piston compresses the cylinder, pure dialysate is forced into the 
dialyzer, but at this time, the effluent stream is functionally closed at the effluent piston 
pump, and thus, dialysate compartment pressures increase rapidly and backfiltration occurs 
(Phase 1).The effluent piston then begins to expand and dialysate moves into the effluent 
cylinder, while the dialysate supply line is still closed at the dialysate pump. Because of 
effluent suction, dialysate compartment pressures fall sharply and water flux from blood 
lumen to dialysate occurs (Phase 2). During the final step, pure dialysate fills the dialysate 
cylinder, and simultaneously used dialysate is drained (Phase 3). 
In an in vitro test of PPPHD with the dual piston pump, in which bovine blood was circulated 
through the blood lumen of the hemodialyzer at 200 ml/min and isotonic saline solution was 
used as dialysate at the rate of 400 ml/min, the phenomena of push (backfiltration) and pull 
(ultrafiltration) were well sustained throughout sessions, and their levels perfectly matched 
those of stroke volumes of the dialysate and effluent pumps, respectively. In addition, as was 
expected, dialysate and effluent piston pumps served as a flow equalizer, and controlled 
isovolumetic dialysate flow rates upstream and downstream of the dialyzer. Hydrostatic 
dialysate pressures were maintained at 520~700 mmHg during the backfiltration phase (Phase 
1) and at -400~-540 mmHg during the ultrafiltration phase (Phase 2). 
 
 
 
 
Fig. 9. Schematic Diagram of PPPHD with Dual Piston Pump. (D, dialysate pump; E, 
effluent pump) 
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Fig. 10. Pulse Generation and Push/Pull during PPPHD with Dual Piston Pump. (D, 
dialysate pump; E, effluent pump) 
In addition, PPPHD is also versatile and can be easily converted to conventional high-flux 
HD. Time-controlled piston operations perform the push and pull operations, but when the 
two piston movements are synchronized alternately (that is, dialysate piston compression 
and effluent piston expansion or dialysate piston expansion and effluent piston compression 
occur simultaneously), dialysate passes through the hemodialyzer without significant flow 
into blood lumen. In this situation, the two piston pumps serve as a flow equalizer and 
dialysis is largely achieved by diffusive mass transfer. 
The PPPHD unit presented was developed recently, and thus, it requires further 
investigation. Convective volume attained during PPPHD was equal to the accumulated 
total dialysate volume, and consequently, this unit delivered the maximally permissible 
level of total volume exchange. This encourages us to speculate on the capability of this unit 
in terms of removing mid-sized uremic toxins. Another issue regarding the enormous fluid 
exchange is the quantification of the contribution made by convection to dialytic efficiency. 
Backfiltration and ultrafiltration repeat in a relatively short time, and despite a large amount 
of filtration, the probability that some ultrafiltrate comes directly from dialysate backfiltered 
during a previous phase cannot be excluded, because that portion of ultrafiltrate does not 
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contribute to depurative efficiency. In addition, forward filtration and backfiltration rates 
exceed the blood flow rate, which implies a reduction in solute concentrations due to 
dilution. As is the case for pre-dilution HDF, this repeated dilution may be expressed by an 
efficiency drop. Finally, although convection commonly inhibits diffusion during HDF, this 
inhibition is expected to be small for PPPHD due to repetitive backfiltration. Although an in 
vitro or in vivo setup revealed that alternate backfiltration has a positive influence on 
inhibiting concentration polarization and permeability reduction, it is believed that 
optimizations, in terms of pulse frequencies and stroke volumes, will further benefit the 
optimal use of membrane convective capacities throughout PPPHD treatments. 
4. Conclusion 
Much evidence shows that HDF delivers better dialysis outcomes than high-flux HD; for 
example, HDF has been shown to improve middle-to-large size molecular removal, allow 
better EPO control, reduce oxidative stress and inflammation (Lornoy et al., 2000, Vaslaki et 
al., 2006, Ward et al., 2000), and even to positively influence patient mortality (Canaud et al., 
2006, Jirka et al., 2006). These benefits have been attributed to the higher convective doses 
permitted during HDF. Furthermore, ultrapure dialysate, required due to the large amount 
of substitution infusion, further inhibits the inflammation risk (Lonnemann, 2000).  
In this chapter, we review HDF techniques that do not require exogenous substitution 
infusion. These techniques must be accompanied by spontaneous fluid restoration, such as, 
backfiltration or ultrafiltrate regeneration (Table 3). A simpler way might be to increase 
forward and backward filtration rates during HD sessions, although this can only be done to 
a limited extent. Much higher efficiencies can be achieved by the two-chamber techniques, 
that is, double high-flux HDF and HFR, which were developed in an effort to increase solute 
removal and shorten treatment times, by separating ultrafiltration and backfiltration, or 
convection and diffusion domains. However, these modalities appear to unavoidably 
increase overall system complexity. Push/pull HDF, which uses a single hemodialyzer, was 
derived by considering phases, rather than physical regions, for forward and backward 
filtration. The pulse push/pull HD described here is also based on the phase-separated use  
 
Modality Filter(s) 
Additional 
components 
TFV § Filtration Reinfusion 
Internal HDF 1 - + 
proximal part 
of dialyzer 
BF 
Double HDF 2 flow restrictor ++ 
hemodialyzer 
(upstream) 
BF 
HFR 2 
adsorbent column,
filtrate pump 
+ 
hemofilter 
(upstream) 
FR 
PP HDF 1 
double-chamber 
pump 
+++ 
whole 
membrane 
BF 
Pulse PP HD 1 - +++ 
whole 
membrane 
BF 
§ Total filtration volume per session (4 hours, L); +, low (<20L); ++, moderate (20-40L); +++ high (>60L) 
Table 3. Infusion-free HDF modalities. (HFR, hemofiltrate reinfusion; TFV, total filtration 
volume; PP, push/pull; FR, filtrate regeneration; BF, backfiltration) 
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of forward filtration and backfiltration using a single high-flux dialyzer. This strategy was 
devised as a result of efforts to modulate flow patterns for extracorporeal dialysis treatment, 
and thus, a unique design for managing dual pulsation through the dialysate compartment 
allows the whole unit to be as simple as the conventional HD unit. 
As these novel HDF strategies evolved, remarkable improvements have been achieved in 
dialysis technologies. Modern dialysis machines offer HDF and HD as default therapies, and 
are also equipped with outstanding monitoring facilities not only for patients (BTM, BVM, 
OCM2), but also for treatments (fail-safe design and high-precision balancing) (Polaschegg, 
2010). In particular, advances in water treatment allow ultrapure replacement fluid to be 
prepared in real time. These technical advancements are certainly lowering the barriers to 
higher convective HDF therapies. 
Therefore, in addition to convective clearances, we believe the PPPHD system should be 
equipped by features that simplify overall treatment and enable dialysis to be performed in 
outside clinics, because this unit allows simple and efficient operation. Future development 
targets designed to accomplish these features include; greater user friendliness (that is, 
intuitive control and operation, fail-safe operations and treatment automation), readily 
available sterile dialysate, accessible maintenance, and a miniaturized unit that is both light 
and portable (without compromising depurative efficiency). A dialysis unit equipped with 
these features may also provide treatment alternatives beyond the current thrice weekly 4-h 
practice, and perhaps allow even daily dialysis for ESRD patients. 
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